Literature DB >> 28550378

Longitudinal Modeling of Depressive Trajectories Among HIV-Infected Men Using Cocaine.

Shibani Mukerji1,2, Roxanna Haghighat1, Vikas Misra1, David R Lorenz1, Alex Holman1, Anupriya Dutta1, Dana Gabuzda3.   

Abstract

Cocaine use is prevalent among HIV-infected individuals. While cross-sectional studies suggest that cocaine users may be at increased risk for depression, long-term effects of cocaine on depressive symptoms remain unclear. This is a longitudinal study of 341 HIV-infected and uninfected men (135 cocaine users and 206 controls) ages 30-60 enrolled in the Multicenter AIDS Cohort Study during 1996-2009. The median baseline age was 41; 73% were African-American. In mixed-effects models over a median of 4.8 years of observation, cocaine use was associated with higher depressive symptoms independent of age, education level, and smoking (n = 288; p = 0.02); HIV infection modified this association (p = 0.03). Latent class mixed models were used to empirically identify distinct depressive trajectories (n = 160). In adjusted models, cocaine use was associated with threefold increased odds of membership in the class with persistent high depressive symptoms (95% confidence interval (CI) 1.38-6.69) and eightfold increased odds (95% CI (2.73-25.83) when tested among HIV-infected subjects only. Cocaine use is a risk factor for chronic depressive symptoms, particularly among HIV-infected men, highlighting the importance of integrating mental health and substance use treatments to address barriers to well-being and successful HIV-care.

Entities:  

Keywords:  Cocaine; Cognitive function; Crack cocaine; Depression; HIV

Mesh:

Substances:

Year:  2017        PMID: 28550378      PMCID: PMC5538019          DOI: 10.1007/s10461-017-1801-y

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  67 in total

1.  Cortisol levels and depression in men and women using heroin and cocaine.

Authors:  Amy B Wisniewski; Todd T Brown; Majnu John; Joseph Cofranceso; Elizabeth T Golub; Erin P Ricketts; Gary Wand; Adrian S Dobs
Journal:  Psychoneuroendocrinology       Date:  2005-09-12       Impact factor: 4.905

2.  Decline in locomotor functions over time in HIV-infected patients.

Authors:  Laura Richert; Mathilde Brault; Patrick Mercié; Frédéric-Antoine Dauchy; Mathias Bruyand; Carine Greib; François Dabis; Fabrice Bonnet; Geneviève Chêne; Patrick Dehail
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

3.  Mixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort study.

Authors:  Samantha A Molsberry; Fabrizio Lecci; Lawrence Kingsley; Brian Junker; Sandra Reynolds; Karl Goodkin; Andrew J Levine; Eileen Martin; Eric N Miller; Cynthia A Munro; Ann Ragin; Ned Sacktor; James T Becker
Journal:  AIDS       Date:  2015-03-27       Impact factor: 4.177

4.  Stigma and sexual health risk in HIV-positive African American young men who have sex with men.

Authors:  Jerilynn Radcliffe; Nathan Doty; Linda A Hawkins; Clare S Gaskins; Rinad Beidas; Bret J Rudy
Journal:  AIDS Patient Care STDS       Date:  2010-08       Impact factor: 5.078

5.  Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort Study.

Authors:  S Shoptaw; R Stall; J Bordon; U Kao; C Cox; X Li; D G Ostrow; M W Plankey
Journal:  Int J STD AIDS       Date:  2012-08       Impact factor: 1.359

6.  The Impact of Comorbidities, Depression, and Substance Use Problems on Quality of Life Among Older Adults Living With HIV.

Authors:  Brett M Millar; Tyrel J Starks; Sitaji Gurung; Jeffrey T Parsons
Journal:  AIDS Behav       Date:  2017-06

7.  Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.

Authors:  Christina S Meade; Nina A Conn; Linda M Skalski; Steven A Safren
Journal:  J Behav Med       Date:  2010-09-21

8.  Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study.

Authors:  Benedetta Milanini; Stephanie Catella; Brandon Perkovich; Pardis Esmaeili-Firidouni; Lauren Wendelken; Robert Paul; Meredith Greene; Robin Ketelle; Victor Valcour
Journal:  AIDS Care       Date:  2017-01-27

Review 9.  Characterizing the cognitive effects of cocaine: a comprehensive review.

Authors:  Desirée B Spronk; Janelle H P van Wel; Johannes G Ramaekers; Robbert J Verkes
Journal:  Neurosci Biobehav Rev       Date:  2013-07-20       Impact factor: 8.989

10.  Illicit drug use and HIV treatment outcomes in a US cohort.

Authors:  Joseph Cofrancesco; Rebecca Scherzer; Phyllis C Tien; Cynthia L Gibert; Heather Southwell; Stephen Sidney; Adrian Dobs; Carl Grunfeld
Journal:  AIDS       Date:  2008-01-30       Impact factor: 4.177

View more
  4 in total

1.  Disparities by age in depressive symptoms and substance use among men who have sex with men living with HIV.

Authors:  Monique J Brown; Julianne M Serovich; Tanja C Laschober; Judy A Kimberly
Journal:  Int J STD AIDS       Date:  2020-05-23       Impact factor: 1.359

2.  Long-Term Trajectories of Depressive Symptoms Among Children Affected by Parental HIV: A 12-Year Follow-Up Study.

Authors:  Qinglu Wu; Junfeng Zhao; Guoxiang Zhao; Xiaoming Li; Hongfei Du; Peilian Chi
Journal:  AIDS Behav       Date:  2022-02-14

3.  Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV.

Authors:  Joseph A Delaney; Robin M Nance; Bridget M Whitney; Frederick L Altice; Xinyuan Dong; Maria Esther Perez Trejo; Mika Matsuzaki; Faye S Taxman; Geetanjali Chander; Irene Kuo; Rob Fredericksen; Lauren N Strand; Joseph J Eron; Elvin Geng; Mari M Kitahata; William C Mathews; Kenneth Mayer; Richard D Moore; Michael S Saag; Sandra Springer; Redonna Chandler; Shoshana Kahana; Heidi M Crane
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.731

4.  The relationship between diabetes and depressive symptoms in men with or at risk of HIV infection.

Authors:  R C Basil; T T Brown; S Haberlen; L H Rubin; M Plankey; J T Becker; J E Lake; F J Palella; S Sarkar
Journal:  HIV Med       Date:  2020-09-24       Impact factor: 3.180

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.